Genesis Healthcare Inc. buy Wells Fargo & Company
Start price
08.08.25
/
50%
€0.38
Target price
08.08.26
€34.30
Performance (%)
-
End price
09.08.26
-
Summary
This prediction was cancelled by the user.Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Genesis Healthcare Inc. | - | - | - |
| iShares Core DAX® | -1.586% | 5.028% | 6.332% |
| iShares Nasdaq 100 | -4.148% | -0.125% | 25.735% |
| iShares Nikkei 225® | -6.302% | 0.528% | 41.384% |
| iShares S&P 500 | -3.225% | 0.470% | 20.449% |
Comments by Wells_Fargo___Compan for this prediction
In the thread Genesis Healthcare Inc. diskutieren
Gen Digital Inc. (NASDAQ: GEN) had its price target raised by analysts at Wells Fargo & Company from $37.00 to $40.00. They now have an "overweight" rating on the stock.
Ratings data for GEN provided by MarketBeat
In the thread Trading Genesis Healthcare Inc.
Die von Wells_Fargo___Compan gewählte maximale Laufzeit wurde überschritten